{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:44:55Z","timestamp":1770482695159,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00417-012-2163-9","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T19:46:45Z","timestamp":1350503205000},"page":"143-152","source":"Crossref","is-referenced-by-count":9,"title":["Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study"],"prefix":"10.1007","volume":"251","author":[{"given":"Arnd","family":"Heiligenhaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrix","family":"Zurek-Imhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Roesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rammrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"2163_CR2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bjo.2008.149039","volume":"93","author":"N Vidovic-Valentincic","year":"2009","unstructured":"Vidovic-Valentincic N, Kraut A, Hawlina M, Stunf S, Rothova A (2009) Intermediate uveitis: long-term course and visual outcome. Br J Ophthalmol 93:477\u2013480","journal-title":"Br J Ophthalmol"},{"key":"2163_CR3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332\u2013336","journal-title":"Br J Ophthalmol"},{"key":"2163_CR4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ophtha.2003.09.031","volume":"111","author":"A Rothova","year":"2004","unstructured":"Rothova A, Berendschot TT, Probst K, van Kooij B et al (2004) Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology 111:954\u2013959","journal-title":"Ophthalmology"},{"key":"2163_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.2006.105528","volume":"91","author":"CC Murphy","year":"2007","unstructured":"Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD (2007) Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Br J Ophthalmol 91:154\u2013156","journal-title":"Br J Ophthalmol"},{"key":"2163_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09273941003637510","volume":"18","author":"E Miserocchi","year":"2010","unstructured":"Miserocchi E, Modorati G, Mosconi P, Colucci A, Bandello F (2010) Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm 18:297\u2013304","journal-title":"Ocul Immunol Inflamm"},{"key":"2163_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-008-8031-3","volume":"42","author":"R Caspi","year":"2008","unstructured":"Caspi R (2008) Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res 42:41\u201350","journal-title":"Immunol Res"},{"key":"2163_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200501000-00001","volume":"25","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Akpek EK (2005) Immunosuppression for posterior uveitis. Retina 25:1\u201318","journal-title":"Retina"},{"key":"2163_CR9","first-page":"25","volume":"7","author":"YB Chen","year":"2008","unstructured":"Chen YB, Sun YA, Gong JP (2008) Effects of rapamycin in liver transplantation. Hepatobiliary Pancreat Dis Int 7:25\u201328","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2163_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00007890-199501000-00005","volume":"59","author":"DK Granger","year":"1995","unstructured":"Granger DK, Cromwell JW, Chen YB, Goswitz JJ, Morrow DT, Beierle FA, Sehgal SN, Canafax DM, Matas AJ (1995) Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation 59:183\u2013186","journal-title":"Transplantation"},{"key":"2163_CR11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","volume":"67","author":"CG Groth","year":"1999","unstructured":"Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattstr\u00f6m C, Charpentier B (1999) Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 67:1036\u20131042","journal-title":"Transplantation"},{"key":"2163_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0041-1345(96)00008-5","volume":"29","author":"BD Kahan","year":"1997","unstructured":"Kahan BD (1997) Sirolimus: a new agent for clinical renal transplantation. Transplant Proc 29:48\u201350","journal-title":"Transplant Proc"},{"key":"2163_CR13","first-page":"122","volume":"20","author":"D BenEzra","year":"1988","unstructured":"BenEzra D, Cohen E, Rakotomalala M, de Courten C, Harris W, Chajek T, Friedman G, Matamoros N (1988) Treatment of endogenous uveitis with cyclosporine A. Transplant Proc 20:122\u2013127","journal-title":"Transplant Proc"},{"key":"2163_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","volume":"112","author":"RB Nussenblatt","year":"1991","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Stevens G Jr, Mellow SD, Green SB (1991) Randomized double masked study of cyclosporine compared to prednisone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138\u2013146","journal-title":"Am J Ophthalmol"},{"key":"2163_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC (2000) Immunosuppressive drugs: the first 50\u00a0years and a glance forward. Immunopharmacology 47:63\u201383","journal-title":"Immunopharmacology"},{"key":"2163_CR16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","volume":"351","author":"PF Halloran","year":"2004","unstructured":"Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715\u20132729","journal-title":"N Engl J Med"},{"key":"2163_CR17","doi-asserted-by":"crossref","unstructured":"Kek\u00e4l\u00e4inen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, P\u00f6ntynen N, Talvensaari K, Perheentupa J, Miettinen A, Arstila TP (2007) A defect of regulatory T cells in patients with autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy. J Immunol 178:1208\u20131215","DOI":"10.4049\/jimmunol.178.2.1208"},{"key":"2163_CR18","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","volume":"178","author":"X Valencia","year":"2007","unstructured":"Valencia X, Yarboro C, Illei G, Lipsky PE (2007) Deficient CD4 + CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178:2579\u20132588","journal-title":"J Immunol"},{"key":"2163_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","volume":"64","author":"W Schuler","year":"1997","unstructured":"Schuler W, Sedrani R, Cottens S, H\u00e4berlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH (1997) SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64:36\u201342","journal-title":"Transplantation"},{"key":"2163_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-3-642-18930-2_14","volume":"279","author":"J Chen","year":"2004","unstructured":"Chen J (2004) Novel regulatory mechanisms of mTOR signaling. Curr Top Microbiol Immunol 279:245\u2013257","journal-title":"Curr Top Microbiol Immunol"},{"key":"2163_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","volume":"64","author":"HJ Schuurman","year":"1997","unstructured":"Schuurman HJ, Cottens S, Fuchs S, Joergensen J, Meerloo T, Sedrani R, Tanner M, Zenke G, Schuler W (1997) SDZ RAD, a new rapamycin derivative: synergism with cyclosporine. Transplantation 64:32\u201335","journal-title":"Transplantation"},{"key":"2163_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto S, Mathis D, Benoist C (2008) The AKT-mTOR axis regulates de novo differentiation of CD4 + Foxp3+ cells. J Exp Med 205:565\u2013574","journal-title":"J Exp Med"},{"key":"2163_CR23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1189\/jlb.1207851","volume":"83","author":"J Kang","year":"2008","unstructured":"Kang J, Huddleston SJ, Fraser JM, Khoruts A (2008) De novo induction of antigen-specific CD4 + CD25 + Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J Leukoc Biol 83:1230\u20131239","journal-title":"J Leukoc Biol"},{"key":"2163_CR24","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer S, Bruno L, Hertweck A, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O\u2019Connor E, Shokat KM, Fisher AG, Merkenschlager M (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105:7797\u20137802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2163_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","volume":"111","author":"R Zeiser","year":"2008","unstructured":"Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS (2008) Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111:453\u2013462","journal-title":"Blood"},{"key":"2163_CR26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00007890-200003150-00011","volume":"69","author":"HJ Schuurman","year":"2000","unstructured":"Schuurman HJ, Ringers J, Schuler W, Slingerland W, Jonker M (2000) Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation. Transplantation 69:737\u2013742","journal-title":"Transplantation"},{"key":"2163_CR27","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0041-1345(98)00589-2","volume":"30","author":"HJ Schuurman","year":"1998","unstructured":"Schuurman HJ, Schuler W, Ringers J, Jonker M (1998) The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation. Transplant Proc 30:2198\u20132199","journal-title":"Transplant Proc"},{"key":"2163_CR28","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/TP.0b013e3181fd01b7","volume":"90","author":"L Gullestad","year":"2010","unstructured":"Gullestad L, Mortensen SA, Eiskjoer H, Riise GC, Mared L, Bj\u00f8rtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Iversen M (2010) Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial. Transplantation 90:1581\u20131589","journal-title":"Transplantation"},{"key":"2163_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0090-9556(24)15260-9","volume":"27","author":"A Crowe","year":"1999","unstructured":"Crowe A, Bruelisauer A, Duerr L, Guntz P, Lemaire M (1999) Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab Dispos 27:627\u2013632","journal-title":"Drug Metab Dispos"},{"key":"2163_CR30","first-page":"693","volume":"281","author":"W Lieberthal","year":"2001","unstructured":"Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol 281:693\u2013706","journal-title":"Am J Physiol"},{"key":"2163_CR31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","volume":"21","author":"G Tenderich","year":"2007","unstructured":"Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R (2007) Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. Clin Transplant 21:536\u2013543","journal-title":"Clin Transplant"},{"key":"2163_CR32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2007.078808","volume":"67","author":"GAW Bruyn","year":"2008","unstructured":"Bruyn GAW, Tate G, Caeiro F, Maldonado-Cocco J, Westhovens R, Tannenbaum H, Bell M, Forre O, Bjorneboe O, Tak PP, Abeywickrama KH, Bernhardt P, van Riel PL, RADD Study Group (2008) Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study. Ann Rheum Dis 67:1090\u20131095","journal-title":"Ann Rheum Dis"},{"key":"2163_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.survophthal.2004.10.004","volume":"50","author":"JG Ladas","year":"2005","unstructured":"Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN (2005) Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol 50:27\u201347","journal-title":"Surv Ophthalmol"},{"key":"2163_CR34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/archopht.119.12.1763","volume":"119","author":"CA Gonzales","year":"2001","unstructured":"Gonzales CA, Ladas JG, Davis JL, Feuer WJ, Holland GN (2001) Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol 119:1763\u20131769","journal-title":"Arch Ophthalmol"},{"key":"2163_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bjo.2006.101675","volume":"91","author":"M Gutfleisch","year":"2007","unstructured":"Gutfleisch M, Spital G, Mingels A, Pauleikhoff D, Lommatzsch A, Heiligenhaus A (2007) Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations. Br J Ophthalmol 91:345\u2013348","journal-title":"Br J Ophthalmol"},{"key":"2163_CR36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1167\/iovs.04-0155","volume":"45","author":"RA Costa","year":"2004","unstructured":"Costa RA, Calucci D, Skaf M, Cardillo JA, Castro JC, Melo LA Jr, Martins MC, Kaiser PK (2004) Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Investig Ophthalmol Vis Sci 45:2399\u20132406","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2163_CR37","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1167\/iovs.04-1383","volume":"46","author":"MA Sandberg","year":"2005","unstructured":"Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL (2005) The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 46:3349\u20133354","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2163_CR38","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/archopht.1994.01090230085026","volume":"112","author":"TW Olsen","year":"1994","unstructured":"Olsen TW, Benegas NM, Joplin AC, Evangelista T, Mindrup EA, Holland EJ (1994) Rapamycin inhibits corneal allograft rejection and neovascularization. Arch Ophthalmol 112:1471\u20131475","journal-title":"Arch Ophthalmol"},{"key":"2163_CR39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"M Guba","year":"2002","unstructured":"Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128\u2013135","journal-title":"Nat Med"},{"key":"2163_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02713689308999487","volume":"12","author":"FG Roberge","year":"1993","unstructured":"Roberge FG, Xu D, Chan CC, de Smet MD, Nussenblatt RB, Chen H (1993) Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction. Curr Eye Res 12:197\u2013203","journal-title":"Curr Eye Res"},{"key":"2163_CR41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.154.2.922","volume":"154","author":"DF Martin","year":"1995","unstructured":"Martin DF, DeBarge LR, Nussenblatt RB, Chan CC, Roberge FG (1995) Synergistic effect of rapamycin and cyclosporine A in the treatment of experimental autoimmune uveoretinitis. J Immunol 154:922\u2013927","journal-title":"J Immunol"},{"key":"2163_CR42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","volume":"89","author":"VA Shanmuganathan","year":"2005","unstructured":"Shanmuganathan VA, Casely EM, Rai D, Powell RJ, Joseph A, Amoaku WM, Dua HS (2005) The efficacy of sirolimus in the treatment of patients with refractory uveitis. Br J Ophthalmol 89:666\u2013669","journal-title":"Br J Ophthalmol"},{"key":"2163_CR43","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","volume":"105","author":"M Battaglia","year":"2005","unstructured":"Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4 + CD25 + Foxp3+ regulatory T cells. Blood 105:4743\u20134748","journal-title":"Blood"},{"key":"2163_CR44","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.transproceed.2010.07.045","volume":"42","author":"D San Segundo","year":"2010","unstructured":"San Segundo D, Fernandez-Fresnedo G, Gago M, Beares I, Ruiz-Criado J, Gonz\u00e1lez M, Ruiz JC, G\u00f3mez-Alamillo C, Arias M, L\u00f3pez-Hoyos M (2010) Number of peripheral regulatory T cells and lymphocyte activation at 3\u00a0months after conversion to mTOR inhibitory therapy. Transplant Proc 42:2871\u20132873","journal-title":"Transplant Proc"},{"key":"2163_CR45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bjo.2006.099192","volume":"91","author":"H Keino","year":"2007","unstructured":"Keino H, Takeuchi M, Usui Y, Hattori T, Yamakawa N, Kezuka T, Sakai JI, Usui M (2007) Supplementation of CD4 + CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol 91:105\u2013110","journal-title":"Br J Ophthalmol"},{"key":"2163_CR46","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1073\/pnas.152665399","volume":"99","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, Brandt EB, Rothenberg ME, Molkentin JD (2002) Defective T cell development and function in calcineurin A beta\u2014deficient mice. Proc Natl Acad Sci U S A 99:9398\u20139403","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2163_CR47","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","volume":"6","author":"JD Fontenot","year":"2005","unstructured":"Fontenot JD, Rasmussen JP, Gavin M, Rudensky AY (2005) A function for interleukin-2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142\u20131151","journal-title":"Nat Immunol"},{"key":"2163_CR48","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/ni1264","volume":"6","author":"LM D\u2019Cruz","year":"2005","unstructured":"D\u2019Cruz LM, Klein L (2005) Development and function of agonist-induced CD25 + Foxp3+ regulatory T cells in the absence of interleukin 2-signaling. Nat Immunol 6:1152\u20131159","journal-title":"Nat Immunol"},{"key":"2163_CR49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.TP.0000164142.98167.4B","volume":"80","author":"CC Baan","year":"2005","unstructured":"Baan CC, van der Mast BJ, Klepper M, Mol WM, Peeters AM, Korevaar SS, Balk AH, Weimar W (2005) Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of Foxp3 in human T cells. Transplantation 80:110\u2013117","journal-title":"Transplantation"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-012-2163-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2163-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T10:52:03Z","timestamp":1744541523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-012-2163-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s00417-012-2163-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,17]]}}}